It is a pharma private limited company based in New Delhi, Delhi, India, established in 2008.
2008 | New Delhi, Delhi, India | ActiveSpurt Pharmaceuticals Private Limited, a active private limited company, was established on 10 July 2008 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24232DL2008PTC180774. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.20 M.
It upholds a compliant status. Its leadership includes Sweety Yadav (Director), Sunit Kumar (Director), Pankaj Kumar (Director). Past directors included Devanand Yadav, Dinesh Kumar Tanwar, Dheeraj Sharma. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No.365,Ghari Mohalla Village Badli, New Delhi, Delhi, 110042.
U24232DL2008PTC180774
180774
10 July 2008
₹0.20 M
₹0.20 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Spurt Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sweety Yadav | Director | 10 Jul 2008 | Current |
| Sunit Kumar | Director | 01 Jul 2009 | Current |
| Pankaj Kumar | Director | 26 Nov 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jun 2011 | Past |
| Pramod Abcsdd | Director | 12 Dec 2008 | Past |
| Pramod Abcsdd | Director | 26 Nov 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Spurt Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 16.52% decrease. The company also saw a substantial improvement in profitability, with a 37.78% increase in profit. The company's net worth Soared by an impressive increase of 28.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Spurt Pharmaceuticals had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Spurt Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Spurt Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spurt Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Spurt Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Spurt Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on Pankaj Kumar was appointed as a Director was appointed as a Director on 26 Nov 2015 & has been associated with this company since 10 years 6 days . was documented.
The activity Sunit Kumar was appointed as a Director was appointed as a Director on 01 Jul 2009 & has been associated with this company since 16 years 5 months . was completed.
Sweety Yadav was appointed as a Director was appointed as a Director on 10 Jul 2008 & has been associated with this company since 17 years 4 months . was recorded as a recent event.
The activity Spurt Pharmaceuticals Private Limited was registered on 10 Jul 2008 with Roc Delhi & aged 17 years 4 months as per MCA records. was completed.
The CIN of Spurt Pharmaceuticals Private Limited is U24232DL2008PTC180774.
Spurt Pharmaceuticals Private Limited is headquartered at H.No.365,Ghari Mohalla Village Badli, New Delhi, Delhi, 110042.
Spurt Pharmaceuticals Private Limited was incorporated on 10 July 2008.
The current directors of Spurt Pharmaceuticals Private Limited are
The primary industry of Spurt Pharmaceuticals Private Limited is Pharma.
Spurt Pharmaceuticals Private Limited is unlisted.
The authorized capital of Spurt Pharmaceuticals Private Limited is ₹0.20 M, and the paid-up capital is ₹0.20 M.
The compliance status of Spurt Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX